Qiagen NV | QIA - Market Capitalization

Stock Price
35.44
Daily Change
1.15 3.34%
Monthly
-4.65%
Yearly
-0.31%
Q2 Forecast
34.40

Qiagen NV reported $7.83B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 5M 5M Sep/2025
argenx SE USD 51.83B 7.52B Dec/2025
Avita Medical AUD 105.47M 35.32M Dec/2025
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
IQVIA Holdings USD 38.39B 6.1B Dec/2025
Organon & Co USD 1.86B 916.43M Dec/2025
Qiagen NV USD 9.9B 207.4M Dec/2025
Revvity USD 10.97B 1.21B Dec/2025
Tectonic Therapeutic USD 390M 96M Dec/2025
Viatris USD 14.34B 2.8B Dec/2025
Xeris Pharmaceuticals USD 1.3B 12M Dec/2025